La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

REM Sleep behavior disorder and REM Sleep without atonia in patients with progressive supranuclear palsy

Identifieur interne : 000730 ( PascalFrancis/Curation ); précédent : 000729; suivant : 000731

REM Sleep behavior disorder and REM Sleep without atonia in patients with progressive supranuclear palsy

Auteurs : Isabelle Arnulf [France] ; Milagros Merino-Andreu [France] ; Frédéric Bloch [France] ; Eric Konofal [France] ; Marie Vidailhet [France] ; Valérie Cochen [France] ; Jean-Philippe Derenne [France] ; Yves Agid [France]

Source :

RBID : Pascal:05-0193219

Descripteurs français

English descriptors

Abstract

Study Objective: To compare sleep characteristics, rapid eye movement (REM) sleep without atonia, and REM sleep behavior disorder (RBD) in patients with progressive supranuclear palsy (tauopathy), patients with Parkinson's disease (a synucleinopathy), and control subjects. Design: Sleep interview, overnight polysomnography, and Multiple Sleep Latency Tests. Patients: Forty-five age- and sex-matched patients with probable progressive supranuclear palsy, (n = 15, aged 68 ± 8 years, 7 men), patients with Parkinson disease (n = 15), and control subjects (n = 15). Settings: Tertiary-care academic hospital. Intervention: N/A. Results: Compared to the 2 other groups, patients with progressive supranuclear palsy had a longer duration of wakefulness after sleep onset and twice as much sleep fragmentation and percentage of stage 1 sleep but had similar apnea-hypopnea indexes, periodic leg movements indexes, and mean daytime sleep latencies. REM sleep percentage was as low in patients with progressive supranuclear palsy (8% ± 6% of total sleep time) as in patients with Parkinson disease (10% ± 4%), versus 20% ± 6% in controls (analysis of variance, P <.0001). Interestingly, patients with progressive supranuclear palsy had percentages of REM sleep without atonia (chin muscle activity: 33% ± 36% of REM sleep) similar to those of patients with Parkinson disease (28% ± 35%) and dramatically higher than those of controls (0.5% ± 1%, analysis of variance, P =.008). Four (27%) patients with progressive supranuclear palsy had more than 50% REM sleep without atonia (as did a similar number of patients with Parkinson disease), and 2 of them (13%, vs 20% of patients with Parkinson disease) had clinical RBD. The four patients with progressive supranuclear palsy with excessive daytime sleepiness slept longer at night than the 11 patients with progressive supranuclear palsy who were alert (442 ± 14 minutes vs 312 ± 74 minutes, student t tests, P =.004), suggesting a primary nonnarcoleptic hypersomnia. Conclusion: REM sleep without atonia and RBD were as frequent in patients with progressive supranuclear palsy as in patients with Parkinson disease. It suggests that the downstream cause of parkinsonism, rather than its primary neuropathology (synucleinopathy vs tauopathy), is a key factor for REM sleep behavior disorder.
pA  
A01 01  1    @0 0161-8105
A02 01      @0 SLEED6
A03   1    @0 Sleep : (N.Y. N.Y.)
A05       @2 28
A06       @2 3
A08 01  1  ENG  @1 REM Sleep behavior disorder and REM Sleep without atonia in patients with progressive supranuclear palsy
A11 01  1    @1 ARNULF (Isabelle)
A11 02  1    @1 MERINO-ANDREU (Milagros)
A11 03  1    @1 BLOCH (Frédéric)
A11 04  1    @1 KONOFAL (Eric)
A11 05  1    @1 VIDAILHET (Marie)
A11 06  1    @1 COCHEN (Valérie)
A11 07  1    @1 DERENNE (Jean-Philippe)
A11 08  1    @1 AGID (Yves)
A14 01      @1 Fédération des Pathologies du Sommeil and Upres EA 2397 @3 FRA @Z 1 aut. @Z 2 aut. @Z 4 aut. @Z 7 aut.
A14 02      @1 Fédération de Neurologie, CIC 9503 and Inserm U289, Hôpital Pitié-Salpêtrière @3 FRA @Z 3 aut. @Z 5 aut. @Z 8 aut.
A14 03      @1 Neurologie, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris @3 FRA @Z 5 aut. @Z 6 aut.
A20       @1 349-354
A21       @1 2005
A23 01      @0 ENG
A43 01      @1 INIST @2 18084 @5 354000125041310120
A44       @0 0000 @1 © 2005 INIST-CNRS. All rights reserved.
A45       @0 38 ref.
A47 01  1    @0 05-0193219
A60       @1 P
A61       @0 A
A64 01  1    @0 Sleep : (New York, NY)
A66 01      @0 USA
C01 01    ENG  @0 Study Objective: To compare sleep characteristics, rapid eye movement (REM) sleep without atonia, and REM sleep behavior disorder (RBD) in patients with progressive supranuclear palsy (tauopathy), patients with Parkinson's disease (a synucleinopathy), and control subjects. Design: Sleep interview, overnight polysomnography, and Multiple Sleep Latency Tests. Patients: Forty-five age- and sex-matched patients with probable progressive supranuclear palsy, (n = 15, aged 68 ± 8 years, 7 men), patients with Parkinson disease (n = 15), and control subjects (n = 15). Settings: Tertiary-care academic hospital. Intervention: N/A. Results: Compared to the 2 other groups, patients with progressive supranuclear palsy had a longer duration of wakefulness after sleep onset and twice as much sleep fragmentation and percentage of stage 1 sleep but had similar apnea-hypopnea indexes, periodic leg movements indexes, and mean daytime sleep latencies. REM sleep percentage was as low in patients with progressive supranuclear palsy (8% ± 6% of total sleep time) as in patients with Parkinson disease (10% ± 4%), versus 20% ± 6% in controls (analysis of variance, P <.0001). Interestingly, patients with progressive supranuclear palsy had percentages of REM sleep without atonia (chin muscle activity: 33% ± 36% of REM sleep) similar to those of patients with Parkinson disease (28% ± 35%) and dramatically higher than those of controls (0.5% ± 1%, analysis of variance, P =.008). Four (27%) patients with progressive supranuclear palsy had more than 50% REM sleep without atonia (as did a similar number of patients with Parkinson disease), and 2 of them (13%, vs 20% of patients with Parkinson disease) had clinical RBD. The four patients with progressive supranuclear palsy with excessive daytime sleepiness slept longer at night than the 11 patients with progressive supranuclear palsy who were alert (442 ± 14 minutes vs 312 ± 74 minutes, student t tests, P =.004), suggesting a primary nonnarcoleptic hypersomnia. Conclusion: REM sleep without atonia and RBD were as frequent in patients with progressive supranuclear palsy as in patients with Parkinson disease. It suggests that the downstream cause of parkinsonism, rather than its primary neuropathology (synucleinopathy vs tauopathy), is a key factor for REM sleep behavior disorder.
C02 01  X    @0 002B17I
C02 02  X    @0 002A26D05
C03 01  X  FRE  @0 Paralysie susnucléaire @5 01
C03 01  X  ENG  @0 Supranuclear paralysis @5 01
C03 01  X  SPA  @0 Parálisis supranuclear @5 01
C03 02  X  FRE  @0 Etude comparative @5 04
C03 02  X  ENG  @0 Comparative study @5 04
C03 02  X  SPA  @0 Estudio comparativo @5 04
C03 03  X  FRE  @0 Individu sain @5 05
C03 03  X  ENG  @0 Healthy subject @5 05
C03 03  X  SPA  @0 Individuo sano @5 05
C03 04  X  FRE  @0 Parkinson maladie @5 07
C03 04  X  ENG  @0 Parkinson disease @5 07
C03 04  X  SPA  @0 Parkinson enfermedad @5 07
C03 05  X  FRE  @0 Sommeil paradoxal @5 10
C03 05  X  ENG  @0 Rapid eye movement sleep @5 10
C03 05  X  SPA  @0 Sueño paradojal @5 10
C03 06  X  FRE  @0 Polysomnographie @5 13
C03 06  X  ENG  @0 Polysomnography @5 13
C03 06  X  SPA  @0 Polisomnografía @5 13
C03 07  X  FRE  @0 Homme @5 20
C03 07  X  ENG  @0 Human @5 20
C03 07  X  SPA  @0 Hombre @5 20
C07 01  X  FRE  @0 Système nerveux pathologie @5 53
C07 01  X  ENG  @0 Nervous system diseases @5 53
C07 01  X  SPA  @0 Sistema nervioso patología @5 53
C07 02  X  FRE  @0 Système nerveux central pathologie @5 54
C07 02  X  ENG  @0 Central nervous system disease @5 54
C07 02  X  SPA  @0 Sistema nervosio central patología @5 54
C07 03  X  FRE  @0 Encéphale pathologie @5 55
C07 03  X  ENG  @0 Cerebral disorder @5 55
C07 03  X  SPA  @0 Encéfalo patología @5 55
C07 04  X  FRE  @0 Extrapyramidal syndrome @5 56
C07 04  X  ENG  @0 Extrapyramidal syndrome @5 56
C07 04  X  SPA  @0 Extrapiramidal síndrome @5 56
C07 05  X  FRE  @0 Maladie dégénérative @5 57
C07 05  X  ENG  @0 Degenerative disease @5 57
C07 05  X  SPA  @0 Enfermedad degenerativa @5 57
C07 06  X  FRE  @0 Electrodiagnostic @5 69
C07 06  X  ENG  @0 Electrodiagnosis @5 69
C07 06  X  SPA  @0 Electrodiagnóstico @5 69
N21       @1 136
N44 01      @1 PSI
N82       @1 PSI

Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:05-0193219

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">REM Sleep behavior disorder and REM Sleep without atonia in patients with progressive supranuclear palsy</title>
<author>
<name sortKey="Arnulf, Isabelle" sort="Arnulf, Isabelle" uniqKey="Arnulf I" first="Isabelle" last="Arnulf">Isabelle Arnulf</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Fédération des Pathologies du Sommeil and Upres EA 2397</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Merino Andreu, Milagros" sort="Merino Andreu, Milagros" uniqKey="Merino Andreu M" first="Milagros" last="Merino-Andreu">Milagros Merino-Andreu</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Fédération des Pathologies du Sommeil and Upres EA 2397</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Bloch, Frederic" sort="Bloch, Frederic" uniqKey="Bloch F" first="Frédéric" last="Bloch">Frédéric Bloch</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Fédération de Neurologie, CIC 9503 and Inserm U289, Hôpital Pitié-Salpêtrière</s1>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Konofal, Eric" sort="Konofal, Eric" uniqKey="Konofal E" first="Eric" last="Konofal">Eric Konofal</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Fédération des Pathologies du Sommeil and Upres EA 2397</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Vidailhet, Marie" sort="Vidailhet, Marie" uniqKey="Vidailhet M" first="Marie" last="Vidailhet">Marie Vidailhet</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Fédération de Neurologie, CIC 9503 and Inserm U289, Hôpital Pitié-Salpêtrière</s1>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Neurologie, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris</s1>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Cochen, Valerie" sort="Cochen, Valerie" uniqKey="Cochen V" first="Valérie" last="Cochen">Valérie Cochen</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Neurologie, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris</s1>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Derenne, Jean Philippe" sort="Derenne, Jean Philippe" uniqKey="Derenne J" first="Jean-Philippe" last="Derenne">Jean-Philippe Derenne</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Fédération des Pathologies du Sommeil and Upres EA 2397</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Agid, Yves" sort="Agid, Yves" uniqKey="Agid Y" first="Yves" last="Agid">Yves Agid</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Fédération de Neurologie, CIC 9503 and Inserm U289, Hôpital Pitié-Salpêtrière</s1>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">05-0193219</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 05-0193219 INIST</idno>
<idno type="RBID">Pascal:05-0193219</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000D04</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000730</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">REM Sleep behavior disorder and REM Sleep without atonia in patients with progressive supranuclear palsy</title>
<author>
<name sortKey="Arnulf, Isabelle" sort="Arnulf, Isabelle" uniqKey="Arnulf I" first="Isabelle" last="Arnulf">Isabelle Arnulf</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Fédération des Pathologies du Sommeil and Upres EA 2397</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Merino Andreu, Milagros" sort="Merino Andreu, Milagros" uniqKey="Merino Andreu M" first="Milagros" last="Merino-Andreu">Milagros Merino-Andreu</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Fédération des Pathologies du Sommeil and Upres EA 2397</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Bloch, Frederic" sort="Bloch, Frederic" uniqKey="Bloch F" first="Frédéric" last="Bloch">Frédéric Bloch</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Fédération de Neurologie, CIC 9503 and Inserm U289, Hôpital Pitié-Salpêtrière</s1>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Konofal, Eric" sort="Konofal, Eric" uniqKey="Konofal E" first="Eric" last="Konofal">Eric Konofal</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Fédération des Pathologies du Sommeil and Upres EA 2397</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Vidailhet, Marie" sort="Vidailhet, Marie" uniqKey="Vidailhet M" first="Marie" last="Vidailhet">Marie Vidailhet</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Fédération de Neurologie, CIC 9503 and Inserm U289, Hôpital Pitié-Salpêtrière</s1>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Neurologie, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris</s1>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Cochen, Valerie" sort="Cochen, Valerie" uniqKey="Cochen V" first="Valérie" last="Cochen">Valérie Cochen</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Neurologie, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris</s1>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Derenne, Jean Philippe" sort="Derenne, Jean Philippe" uniqKey="Derenne J" first="Jean-Philippe" last="Derenne">Jean-Philippe Derenne</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Fédération des Pathologies du Sommeil and Upres EA 2397</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Agid, Yves" sort="Agid, Yves" uniqKey="Agid Y" first="Yves" last="Agid">Yves Agid</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Fédération de Neurologie, CIC 9503 and Inserm U289, Hôpital Pitié-Salpêtrière</s1>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Sleep : (New York, NY)</title>
<title level="j" type="abbreviated">Sleep : (N.Y. N.Y.)</title>
<idno type="ISSN">0161-8105</idno>
<imprint>
<date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Sleep : (New York, NY)</title>
<title level="j" type="abbreviated">Sleep : (N.Y. N.Y.)</title>
<idno type="ISSN">0161-8105</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Comparative study</term>
<term>Healthy subject</term>
<term>Human</term>
<term>Parkinson disease</term>
<term>Polysomnography</term>
<term>Rapid eye movement sleep</term>
<term>Supranuclear paralysis</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Paralysie susnucléaire</term>
<term>Etude comparative</term>
<term>Individu sain</term>
<term>Parkinson maladie</term>
<term>Sommeil paradoxal</term>
<term>Polysomnographie</term>
<term>Homme</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Study Objective: To compare sleep characteristics, rapid eye movement (REM) sleep without atonia, and REM sleep behavior disorder (RBD) in patients with progressive supranuclear palsy (tauopathy), patients with Parkinson's disease (a synucleinopathy), and control subjects. Design: Sleep interview, overnight polysomnography, and Multiple Sleep Latency Tests. Patients: Forty-five age- and sex-matched patients with probable progressive supranuclear palsy, (n = 15, aged 68 ± 8 years, 7 men), patients with Parkinson disease (n = 15), and control subjects (n = 15). Settings: Tertiary-care academic hospital. Intervention: N/A. Results: Compared to the 2 other groups, patients with progressive supranuclear palsy had a longer duration of wakefulness after sleep onset and twice as much sleep fragmentation and percentage of stage 1 sleep but had similar apnea-hypopnea indexes, periodic leg movements indexes, and mean daytime sleep latencies. REM sleep percentage was as low in patients with progressive supranuclear palsy (8% ± 6% of total sleep time) as in patients with Parkinson disease (10% ± 4%), versus 20% ± 6% in controls (analysis of variance, P <.0001). Interestingly, patients with progressive supranuclear palsy had percentages of REM sleep without atonia (chin muscle activity: 33% ± 36% of REM sleep) similar to those of patients with Parkinson disease (28% ± 35%) and dramatically higher than those of controls (0.5% ± 1%, analysis of variance, P =.008). Four (27%) patients with progressive supranuclear palsy had more than 50% REM sleep without atonia (as did a similar number of patients with Parkinson disease), and 2 of them (13%, vs 20% of patients with Parkinson disease) had clinical RBD. The four patients with progressive supranuclear palsy with excessive daytime sleepiness slept longer at night than the 11 patients with progressive supranuclear palsy who were alert (442 ± 14 minutes vs 312 ± 74 minutes, student t tests, P =.004), suggesting a primary nonnarcoleptic hypersomnia. Conclusion: REM sleep without atonia and RBD were as frequent in patients with progressive supranuclear palsy as in patients with Parkinson disease. It suggests that the downstream cause of parkinsonism, rather than its primary neuropathology (synucleinopathy vs tauopathy), is a key factor for REM sleep behavior disorder.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0161-8105</s0>
</fA01>
<fA02 i1="01">
<s0>SLEED6</s0>
</fA02>
<fA03 i2="1">
<s0>Sleep : (N.Y. N.Y.)</s0>
</fA03>
<fA05>
<s2>28</s2>
</fA05>
<fA06>
<s2>3</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>REM Sleep behavior disorder and REM Sleep without atonia in patients with progressive supranuclear palsy</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>ARNULF (Isabelle)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>MERINO-ANDREU (Milagros)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>BLOCH (Frédéric)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>KONOFAL (Eric)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>VIDAILHET (Marie)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>COCHEN (Valérie)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>DERENNE (Jean-Philippe)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>AGID (Yves)</s1>
</fA11>
<fA14 i1="01">
<s1>Fédération des Pathologies du Sommeil and Upres EA 2397</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Fédération de Neurologie, CIC 9503 and Inserm U289, Hôpital Pitié-Salpêtrière</s1>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Neurologie, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris</s1>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA20>
<s1>349-354</s1>
</fA20>
<fA21>
<s1>2005</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>18084</s2>
<s5>354000125041310120</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2005 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>38 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>05-0193219</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Sleep : (New York, NY)</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Study Objective: To compare sleep characteristics, rapid eye movement (REM) sleep without atonia, and REM sleep behavior disorder (RBD) in patients with progressive supranuclear palsy (tauopathy), patients with Parkinson's disease (a synucleinopathy), and control subjects. Design: Sleep interview, overnight polysomnography, and Multiple Sleep Latency Tests. Patients: Forty-five age- and sex-matched patients with probable progressive supranuclear palsy, (n = 15, aged 68 ± 8 years, 7 men), patients with Parkinson disease (n = 15), and control subjects (n = 15). Settings: Tertiary-care academic hospital. Intervention: N/A. Results: Compared to the 2 other groups, patients with progressive supranuclear palsy had a longer duration of wakefulness after sleep onset and twice as much sleep fragmentation and percentage of stage 1 sleep but had similar apnea-hypopnea indexes, periodic leg movements indexes, and mean daytime sleep latencies. REM sleep percentage was as low in patients with progressive supranuclear palsy (8% ± 6% of total sleep time) as in patients with Parkinson disease (10% ± 4%), versus 20% ± 6% in controls (analysis of variance, P <.0001). Interestingly, patients with progressive supranuclear palsy had percentages of REM sleep without atonia (chin muscle activity: 33% ± 36% of REM sleep) similar to those of patients with Parkinson disease (28% ± 35%) and dramatically higher than those of controls (0.5% ± 1%, analysis of variance, P =.008). Four (27%) patients with progressive supranuclear palsy had more than 50% REM sleep without atonia (as did a similar number of patients with Parkinson disease), and 2 of them (13%, vs 20% of patients with Parkinson disease) had clinical RBD. The four patients with progressive supranuclear palsy with excessive daytime sleepiness slept longer at night than the 11 patients with progressive supranuclear palsy who were alert (442 ± 14 minutes vs 312 ± 74 minutes, student t tests, P =.004), suggesting a primary nonnarcoleptic hypersomnia. Conclusion: REM sleep without atonia and RBD were as frequent in patients with progressive supranuclear palsy as in patients with Parkinson disease. It suggests that the downstream cause of parkinsonism, rather than its primary neuropathology (synucleinopathy vs tauopathy), is a key factor for REM sleep behavior disorder.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17I</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002A26D05</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Paralysie susnucléaire</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Supranuclear paralysis</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Parálisis supranuclear</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Etude comparative</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Comparative study</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Estudio comparativo</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Individu sain</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Healthy subject</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Individuo sano</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Parkinson maladie</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Parkinson disease</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Parkinson enfermedad</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Sommeil paradoxal</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Rapid eye movement sleep</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Sueño paradojal</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Polysomnographie</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Polysomnography</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Polisomnografía</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>53</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>53</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>53</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Système nerveux central pathologie</s0>
<s5>54</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>54</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>54</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Encéphale pathologie</s0>
<s5>55</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>55</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>55</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Extrapyramidal syndrome</s0>
<s5>56</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>56</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>56</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>57</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>57</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>57</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Electrodiagnostic</s0>
<s5>69</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Electrodiagnosis</s0>
<s5>69</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Electrodiagnóstico</s0>
<s5>69</s5>
</fC07>
<fN21>
<s1>136</s1>
</fN21>
<fN44 i1="01">
<s1>PSI</s1>
</fN44>
<fN82>
<s1>PSI</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000730 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000730 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:05-0193219
   |texte=   REM Sleep behavior disorder and REM Sleep without atonia in patients with progressive supranuclear palsy
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024